About
Trial Library, founded in 2022 in San Francisco, is an AI-powered clinical trial accessibility and navigation platform serving healthcare providers and patients.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Company· 12
Investor· 7
Founders / team· 1
Founders / core team
Investors
Funding history
- 2025-12Series A$10M
Investors · Overwater Ventures, Next Ventures, How Women Invest, Civilization Ventures, Sanofi, SemperVirens, Lux Capital
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Trial Library
AI-enabled clinical trial access and navigation platform (for healthcare providers / patients)
Series A · $10M · 2025-12
$10M
United States
BusinessLatest roundTotal raisedDate- Health Universe
Secure, compliant AI agent infrastructure for healthcare providers, applied to medical records, oncology, clinical trials and operations
Seed · $10M · 2026-03
$10M - Enzo Health
Analyzes clinical documentation and patient data to help home health agencies manage reimbursement, compliance and eligibility decisions
Series A · $26M · 2026-05
$26M - Sage Care
AI agents for patient navigation and scheduling at healthcare providers
Undisclosed · $20M · 2025-10
$20M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Iomed
NLP-based data extraction from medical records, clinical trials and patient surveys
Series A · $11M · 2023-09
$11M - IgniteData
Automatically transfers patient data from electronic health records to clinical trial electronic data capture systems
Seed · $8M · 2024-06
$8M - Vocca
Specialty AI voice front desk for medical practices that answers patient calls and completes scheduling and administrative tasks directly in scheduling/EHR systems
Series A · $25M · 2026-10
$25M
Other / unspecified
BusinessLatest roundTotal raisedDate- QuantHealth
Helps researchers maximize clinical trial success rates
Series A · $17M · 2024-01
$17M - Reliant AI
Uses generative AI to help biopharma companies organize and analyze data for clinical trials or scientific publications
Seed · $11M · 2024-08
$11M - Sarborg
AI agents that help pharmaceutical companies optimize drug repurposing and clinical trial decisions
Seed · $10M · 2025-08
$10M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
General Catalyst
39 Life Sciences deals in the last 24 months · 25 at a nearby stage · 35 in Silicon Valley
Request intro →Y Combinator
38 Life Sciences deals in the last 24 months · 33 at a nearby stage · 31 in Silicon Valley
Request intro →Andreessen Horowitz
24 Life Sciences deals in the last 24 months · 12 at a nearby stage · 22 in Silicon Valley
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in Silicon Valley
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in Silicon Valley
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 11 at a nearby stage · 14 in Silicon Valley
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.